Patent details

EP4279082 Title: FORMULATIONS

Basic Information

Publication number:
EP4279082
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP231876152
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS
French Title of Invention:
FORMULATIONS
German Title of Invention:
FORMULIERUNGEN
SPC Number:

Dates

Filing date:
16/01/2020
Grant date:
04/03/2026
EP Publication Date:
22/11/2023
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/03/2026
EP B1 Publication Date:
04/03/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/01/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/02/2026
 
 

Name:
Immunocore Limited
Address:
92 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/03/2026
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
EBNER, Martin
Address:
United Kingdom (GB)

2

Name:
GRUDZIEN, Lukasz
Address:
United Kingdom (GB)

3

Name:
JOHNSON, Andy
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201900658
Priority Date:
17/01/2019
Priority Country:
United Kingdom (GB)

2

Priority Number:
201905105
Priority Date:
10/04/2019
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/00; A61K 47/12; A61K 47/26; A61K 38/00; A61K 38/17;

Publication

European Patent Bulletin

Issue number:
202610
Publication date:
04/03/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
19/03/2026 Power Of Attorney 1
20/03/2026 Outgoing Correspondence 1